Adagio Medical Holdings reported net income of -$6.72M for the quarter ended Jun 2026. This income statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.76M | 0.78M | 0.78M | 0.99M | 14.54M | 15.20M | 15.38M | 15.38M | 15.38M | 16.58M | 22.21M | 22.21M |
| Revenue & cost | ||||||||||||
| Revenue | 0.04M | 0.08M | 0.03M | 0.25M | 0.13M | |||||||
| Gross Profit | -0.21M | -0.26M | -0.52M | -0.43M | -0.28M | -0.25M | -0.34M | -0.03M | -0.06M | |||
| Operating items | ||||||||||||
| Research & DevelopmentR&D | 4.42M | 1.77M | 3.47M | 2.87M | 1.22M | 3.66M | 1.97M | 2.77M | 2.23M | 2.74M | 2.45M | |
| Selling, General & AdministrativeSG&A | 4.45M | 3.30M | 4.83M | 3.37M | 2.93M | 3.48M | 2.40M | 2.92M | 1.68M | 2.46M | 2.48M | |
| Other Operating ExpensesOther Opex | 0.25M | 0.33M | 0.54M | 0.68M | 0.41M | 0.25M | 0.34M | 0.03M | 0.06M | |||
| Operating ExpensesOpex | 9.12M | 5.41M | 8.84M | 6.91M | 4.56M | 7.40M | 4.72M | 5.72M | 3.97M | 5.20M | 4.93M | |
| Operating IncomeOp. Inc | -9.08M | -5.33M | -8.81M | -6.66M | -4.42M | -7.40M | -4.72M | -5.72M | -3.97M | -5.20M | -4.93M | |
| EBIT | -9.08M | -5.33M | -8.81M | -6.66M | -4.42M | -7.40M | -4.72M | -5.72M | -3.97M | -5.20M | -4.93M | |
| Non-operating items | ||||||||||||
| Non Operating Interest Expenses | 0.48M | 0.58M | 0.75M | 0.76M | 0.43M | 0.66M | 0.72M | 0.75M | 0.78M | 0.78M | 0.81M | |
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.00M | 0.00M | 0.00M | 0.17M | 0.16M | 0.10M | 0.08M | 0.13M | 0.11M | 0.07M | |
| Other Non Operating IncomeOther Non Op Inc. | -0.12M | 0.09M | -0.04M | 0.01M | 0.07M | -0.05M | 0.10M | 0.01M | 0.04M | 0.07M | -0.07M | |
| Non Operating IncomeNon Op. Inc. | -1.68M | -3.29M | 0.80M | 0.93M | 8.03M | -0.32M | 0.77M | -4.40M | 0.66M | -1.79M | -1.78M | |
| Net income details | ||||||||||||
| EBT | -9.56M | -5.91M | -9.57M | -7.42M | -4.69M | -7.89M | -5.33M | -6.39M | -4.61M | -5.87M | -5.67M | |
| Profit After TaxPAT | -10.76M | -8.63M | -8.02M | -5.73M | 3.61M | -7.77M | -3.99M | -10.12M | -3.31M | -7.04M | -6.72M | |
| Income from Continuing OperationsIncome (Continuing) | -9.56M | -5.91M | -9.57M | -7.42M | -4.69M | -7.89M | -5.33M | -6.39M | -4.61M | -5.87M | -5.67M | |
| Consolidated Net IncomeConsol Net Inc. | -9.56M | -5.91M | -9.57M | -7.42M | -4.69M | -7.89M | -5.33M | -6.39M | -4.61M | -5.87M | -5.67M | |
| Income towards Parent CompanyParent Net Inc | -9.56M | -5.91M | -9.57M | -7.42M | -4.69M | -7.89M | -5.33M | -6.39M | -4.61M | -5.87M | -5.67M | |
| Net Income towards Common StockholdersNet Income | -9.56M | -5.91M | -9.57M | -7.42M | -4.69M | -7.89M | -5.33M | -6.39M | -4.61M | -5.87M | -5.67M | |
| Additional items | ||||||||||||
| EPS (Basic) | -12.59 | -7.78 | -12.27 | -9.51 | -0.33 | -0.51 | -0.35 | -0.42 | -0.28 | -0.26 | -0.26 | |
| EPS (Diluted) | -12.59 | -7.78 | -12.60 | -9.77 | -0.29 | -0.51 | -0.35 | -0.42 | -0.28 | -0.26 | -0.26 | |
| Shares Outstanding | 0.76M | 0.76M | 0.78M | 0.78M | 14.06M | 14.77M | 15.38M | 15.38M | 15.38M | 16.58M | 22.21M | 22.21M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.76M | 0.76M | 0.76M | 0.76M | 16.06M | 14.77M | 15.38M | 15.38M | 15.38M | 16.58M | 22.21M | 22.21M |
| EBITDA | -9.08M | -5.33M | -8.81M | -6.66M | -4.42M | -7.40M | -4.72M | -5.72M | -3.97M | -5.20M | -4.93M | |
| Interest ExpensesInt Expense | 0.48M | 0.58M | 0.75M | 0.76M | 0.43M | 0.66M | 0.72M | 0.75M | 0.78M | 0.78M | 0.81M |